Alliqua BioMedical

Screen of Nasdaq stock tickers

Biotech

Adynxx merges with Alliqua, snagging Nasdaq listing

The reverse merger comes six months after Adynxx committed to advancing pain drug brivoligide, despite the candidate coming up short in phase 2.

Nick Paul Taylor Oct 12, 2018 8:45am

stethoscope on top of a book next to a pen

Alliqua’s MIST wound-care system eligible for Medicare coverage in FL, Caribbean territories

Oct 10, 2016 11:39am